MoneyWorks4Me

Biocon informs about press release

29 Aug 2024 Evaluate
Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1775.40
Dr. Reddys Labs. 1182.05
Cipla 1328.95
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..